(PR1J) Amundi Prime Japan DR (D) - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1931974775 • Japan Large-Cap Equity
PR1J: Japanese, Stocks, Equities
Amundi Prime Japan UCITS ETF DR (D) is a Luxembourg-domiciled exchange-traded fund listed on XETRA under the ticker symbol PR1J. It is designed to provide exposure to large-cap Japanese equities, making it a targeted option for investors seeking to allocate to Japans prominent companies.
The fund tracks the Morningstar Japan TME NR JPY index, which offers a broad representation of Japans large-cap market. With an AUM of 177.46 billion EUR, it is a substantial fund, indicating significant investor interest and liquidity. This size often translates to tighter bid-ask spreads, which can be advantageous for both retail and institutional traders.
As a UCITS-compliant ETF, it adheres to strict regulatory standards, providing a level of investor protection and transparency. The funds structure allows it to be traded on XETRA, appealing to European investors who prefer the familiarity of a regulated market. Its focus on large-cap Japanese equities means it is heavily exposed to sectors such as technology, automotive, and financials, which are pivotal to Japans economy.
One key consideration for investors is the funds tracking difference, which measures how closely it follows its underlying index. While historical data would be needed to assess this, the funds scale often helps in minimizing deviations. Additionally, as an ETF, it offers the flexibility to trade throughout the day, unlike mutual funds that settle at the end of the trading day.
Its worth noting that the fund does not provide explicit P/E, P/B, or P/S ratios, as these are typically metrics associated with actively managed funds or individual stocks. Instead, investors should evaluate it based on its ability to replicate the Morningstar Japan TME NR JPY index and its overall cost structure.
Additional Sources for PR1J ETF
PR1J ETF Overview
Market Cap in USD | 186,383m |
Category | Japan Large-Cap Equity |
TER | 0.05% |
IPO / Inception | 2019-01-30 |
PR1J ETF Ratings
Growth 5y | 54.7% |
Fundamental | - |
Dividend | 56.7% |
Rel. Strength Industry | -14.4 |
Analysts | - |
Fair Price Momentum | 26.21 EUR |
Fair Price DCF | - |
PR1J Dividends
Dividend Yield 12m | 1.90% |
Yield on Cost 5y | 2.72% |
Annual Growth 5y | 5.58% |
Payout Consistency | 97.7% |
PR1J Growth Ratios
Growth Correlation 3m | 54.3% |
Growth Correlation 12m | 56.3% |
Growth Correlation 5y | 77.9% |
CAGR 5y | 7.96% |
CAGR/Max DD 5y | 0.35 |
Sharpe Ratio 12m | 0.40 |
Alpha | -7.42 |
Beta | 0.85 |
Volatility | 13.41% |
Current Volume | 4.9k |
Average Volume 20d | 6.7k |
As of February 22, 2025, the stock is trading at EUR 29.16 with a total of 4,871 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +3.29%, over three months by +5.19% and over the past year by +9.05%.
Partly, yes. Based on ValueRay Analyses, Amundi Prime Japan DR (D) (XETRA:PR1J) is currently (February 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.67 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PR1J as of February 2025 is 26.21. This means that PR1J is currently overvalued and has a potential downside of -10.12%.
Amundi Prime Japan DR (D) has no consensus analysts rating.
According to ValueRays Forecast Model, PR1J Amundi Prime Japan DR (D) will be worth about 31.5 in February 2026. The stock is currently trading at 29.16. This means that the stock has a potential upside of +7.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.5 | 7.9% |